The Great Cholesterol Scam

Cholesterol is essential for life. It is a building block of cell membranes, a precursor to important hormones such as testosterone, and a key component of the immune system.

Yet for decades, medical research and practice have treated cholesterol – and especially LDL (“bad cholesterol”) – as the main enemy.

This line of thinking is based on the so-called cholesterol hypothesis, which claims that high cholesterol causes cardiovascular disease. The problem? This the hypothesis has never been proven. It's just a hypothesis, to this day. A shaky one, that's all.

Studies show that low cholesterol is associated with increased mortality, especially in the elderly. The body produces cholesterol in large quantities every single day for a reason. It even has its own cholesterol production going on in the brain, because the brain needs extra and can't get it from food because of the blood-brain barrier. See also this study that shows increased mortality with low cholesterol:

• Low Cholesterol Levels Associated with Increased Mortality

So artificially lowering cholesterol with statins often has unintended consequences, and we really have no idea what we're doing.

What we know for sure is that statins cause muscle wasting, reduced immune function and hormonal imbalances, such as a major drop in testosterone. Statins do not treat the cause to cardiovascular diseases; they address a biomarker which in many cases is irrelevant or even protective.

And this is how modern medicine often works; we treat symptoms instead of causesWe suppress the body's natural reaction to an underlying problem, without always understanding its complex connections. For most likely this reaction was the body's natural defense mechanism – a kind of medicine in itself – which we, in our limited understanding, suppressed with chemicals.

It's like taking painkillers because we have a stone in our shoe.

Statins for cholesterol

Since their introduction in the 1980s, the use of statins has been portrayed as a medical revolution in the fight against cardiovascular disease. Today, statins are among the most prescribed drugs in the world, but behind this lies a deeper, uncomfortable truth:

The premises for the whole cholesterol hypothesis, and thus the statins' justification, is fundamentally wrong.

This is not just a medical misunderstanding; it is possibly one of the biggest scams in modern medicine, and many prominent physicians and scientists actively promotes the view that statins are a hoax.

When you look at what is called NNT – Number Needed to Treat, you need to treat upwards of 500 people for 5 years to prevent a single cardiovascular event. The effect for the other 499 was therefore exclusively side effectsEven doctors haven't looked into this, and firmly believe that statins are good.

The problem is that the knowledge base is corrupt – not the actors we seek out in everyday life.

In the large meta-analysis "Statins and all-cause mortality in high-risk primary prevention: a meta-analysis of 11 randomized controlled trials involving 65,229 participants» one concludes that «This literature-based meta-analysis did not find evidence for the benefit of statin therapy on all-cause mortality in a high-risk primary prevention set-up. «

In Norwegian: «This literature-based meta-analysis found no evidence that statin therapy reduces all-cause mortality in a high-risk population for primary prevention. "

The real problem: Glycated cholesterol

What really damages blood vessels is not healthy cholesterol particles, but glycated cholesterols – i.e. cholesterol that has been damaged by glucose og oxidationThese disrupted particles can trigger inflammation and contribute to plaque formation, but this has little to do with the crowd cholesterol in the blood.

Factors like high blood sugar, insulin resistance, and chronic inflammation are the real culprits, but the industry has chosen a simpler narrative: “The lower the LDL, the better.”

Dr. Paul Mason, a leading expert in metabolic health and exercise physiology, has been clear that it is not fresh cholesterol particles that cause problems, but so-called "bad cholesterol» – particles that have been glycated.

This occurs when cholesterol particles are exposed to persistently high blood sugar levels, which leads to structural damage to the particles. Mason explains how these damaged particles can more easily become lodged in the walls of blood vessels and trigger inflammation, which is the real driver of atherosclerosis.

He has also pointed out that the traditional focus on LDL levels overlooks this key factor, which is often linked to insulin resistance and metabolic dysfunction.

"If we want to reduce the risk of cardiovascular disease, we need to address the cause, which is chronic high blood sugar and insulin resistance – not healthy cholesterol particles," says Mason.

Side effects and long-term consequences

Statins have a number of well-documented side effects, including:

• Muscle wasting and chronic muscle pain.
• Reduced production of coenzyme Q10, which is important for energy production in cells.
• Reduced testosterone and hormonal imbalances.
• Weaker immune system, which can make the body more vulnerable to infections.
• Neurological problems such as memory loss and cognitive impairment.

Ironically, some studies have also shown that low cholesterol levels may be associated with increased risk of cancer og neurodegenerative diseases such as Parkinson's, Alzheimer's and Huntington's.

How We Were Deceived: Gaslighting and the Industry's Grip

The pharmaceutical industry has skillfully manipulated both doctors and patients. They have shifted the focus from the original question “Need we to lower cholesterol?” to the far narrower question “How did I Can we lower cholesterol?

If we never answered the first, why are we working so hard on the second?

This rhetorical move has been a stroke of genius for the industry, which has made billions from statins. By dominating research, guidelines, and medical education, they have effectively eliminated critical voices and cemented the cholesterol hypothesis as “truth.”

The voices that challenge the narrative

One of the most prominent critics of the cholesterol hypothesis is Dr. Malcolm Kendrick, the author of the book The Great Cholesterol ConKendrick provides a detailed review of how research on cholesterol is often poorly conducted, misreported, and heavily influenced by financial interests. His work points out:

• How cholesterol levels do not correlate with heart attacks in most people.
• That inflammation, not cholesterol, is the real cause of cardiovascular disease.
• That low cholesterol levels are often associated with higher mortality rate, especially in the elderly.

Kendrick's book serves as a platform for understanding how statins have become an industrial success at the expense of patients' health and the integrity of science.

Another important critic of the cholesterol hypothesis is Dr. Aseem Malhotra, a British cardiologist (heart doctor) and one of the most influential voices in preventive heart health.

Known as the cardiologist “whose advice was always sought,” Malhotra has long been a respected authority in his field, focusing on how lifestyle can be used to prevent cardiovascular disease. He points out how the focus on cholesterol as a risk factor has diverted attention from the real causes of disease, such as poor diet, physical inactivity, and chronic stress. He highlights:

• The importance of diet: Dr. Malhotra argues that a low-processed diet, with minimal sugar and refined carbohydrates, is key to reducing inflammation and improving heart health. He has also promoted the Mediterranean diet as an alternative to statin use.
  
• Inflammation over cholesterol: He believes that inflammation, not LDL levels, is the biggest driver of cardiovascular disease, and that lowering cholesterol by itself does little to address this.
  
• A corrupt system: Dr. Malhotra has been open about how the pharmaceutical industry has influenced research and guidelines, and he believes that the financial incentives behind statins have overshadowed the best interests of patients.

Dr. Aseem Malhotra's approach is based on the principle of addressing the cause rather than the symptom. He has been a strong critic of guidelines that focus on medicating healthy people with statins, which he believes leads to unnecessary risks and harms.

More critics of statins

Two other prominent critics who have challenged the established cholesterol hypothesis are: Dr. Zoe Harcombe og Dr. Uffe RavnskovBoth have done extensive work to uncover the errors in the prevailing understanding of cholesterol and heart disease.

Dr. Zoe Harcombe, nutrition researcher and experienced debunker of statistics and other lies, has been clear about how faulty dietary advice and an exaggerated fear of fat have contributed to the modern epidemic of metabolic disease.

She points out that high cholesterol is often wrongly made a scapegoat, while the real causes of cardiovascular disease – such as overconsumption of refined carbohydrates, chronic inflammation and insulin resistance – are ignored.

Harcombe has stated: "The focus on lowering cholesterol has distracted us from the real drivers of poor health, which are often rooted in the overconsumption of processed and sugary foods."

Dr. Uffe Ravnskov, a Swedish doctor and author of the book The Cholesterol Myths, has dedicated his career to refuting claims that high cholesterol is a direct cause of heart disease.

Ravnskov has reviewed a large body of research data and concludes that the link between LDL cholesterol and heart disease has been greatly exaggerated. He argues that cholesterol plays an important protective role in the body, and that the focus on lowering LDL has been misguided.

Ravnskov also points out: "The cholesterol hypothesis is based on cherry-picked data and ignores findings that contradict it. It's time to stop demonizing cholesterol.”

Together, Harcombe and Ravnskov represent a powerful challenge to the traditional narrative, and their work highlights the importance of looking at cardiovascular disease through a broader, more holistic lens.

A way forward

It is time to rethink the entire paradigm surrounding cholesterol and cardiovascular disease. The focus should shift from artificial lowering of cholesterol without fully understanding why, to address the real causes behind disease, such as insulin resistance, inflammation and poor lifestyle.

Statins should never have been on the market, and it's time to question why they're still there.

This is not just about health. It is about integrity, scientific honesty, and putting the best interests of patients ahead of financial interests. Cholesterol is not the enemy, and the industry and politics that make it so should soon be exposed and held accountable.

SOURCES

Photo: Shutterstock license

Anyone can comment by logging in with their Facebook or Google accounts.. Norwegian Carnivory is not health care. You must seek medical attention for medical problems.

Written 2025 © Norwegian Carnivory